RVVQF OTC
RavenQuest BioMed Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +0.0%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+1018.8% ▲
Gross Profit
$801K
+5368.1% ▲
Operating Income
-$17M
-2575.4% ▼
Net Income
-$30M
-823.0% ▼
EPS (Diluted)
$-0.33
-230.0% ▼
EBITDA
-$27M
-764.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $112K | $1M |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +1018.8% |
| Cost of Revenue | $0 | $0 | $0 | $98K | $455K |
| Gross Profit | $0 | $0 | $0 | $15K | $801K |
| Gross Margin | — | — | — | 13.0% | 63.7% |
| R&D Expenses | $0 | $0 | $0 | $0 | $80K |
| SG&A Expenses | $84K | $79K | $80K | $634K | $11M |
| Operating Expenses | $76K | $83K | $81K | $656K | $801K |
| Operating Income | -$76K | -$83K | -$71K | -$642K | -$17M |
| Operating Margin | — | — | — | -571.4% | -1366.4% |
| Interest Expense | $0 | $0 | $0 | $147K | $2M |
| Income Before Tax | -$61K | -$76K | -$81K | -$3M | -$31M |
| Tax Expense | $0 | $0 | $0 | $0 | -$578K |
| Net Income | -$61K | -$76K | -$81K | -$3M | -$30M |
| Net Margin | — | — | — | -2938.1% | -2423.9% |
| EPS (Diluted) | $-0.00 | $-0.00 | $-0.00 | $-0.10 | $-0.33 |
| EBITDA | -$62K | -$76K | -$81K | -$3M | -$27M |
| Shares Outstanding | 29M | 29M | 29M | 32M | 91M |